MPT vs WELL: Which Is the Better Buy in 2026?

Last updated October 2026

Short answer

WELL is the larger of the two ($169.23B market cap): the incumbent the market prices for continued execution (73.85x forward earnings, beta 0.75). MPT is the smaller challenger ($1.80B), cheaper on forward earnings (60.20x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

MPT vs WELL: the tie-breaker metrics

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricMPTWELLWhat it tells you
Market cap$1.80B$169.23BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E60.2073.85Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Beta1.490.75Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range0% of range75% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book0.403.64How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: MPT is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how MPT and WELL affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MPT and WELL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MPT and WELL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Medical Properties Trust (MPT) do?

Medical Properties Trust, Inc. trades on the New York Stock Exchange under the ticker MPT and is one of the largest owners of hospital real estate in the world. Its model is sale-leaseback: it buys hospital buildings from operators, then leases the property back under long-term net leases where the tenant covers taxes, insurance, and maintenance. The portfolio spans general acute care hospitals, behavioral health facilities, and post-acute sites across the United States and Europe, and revenue comes almost entirely from contractual rent plus interest on loans MPT has made to some of its tenants.

Full MPT guide

What does Welltower (WELL) do?

Welltower Inc. is the largest healthcare REIT in the world, owning a portfolio of senior housing, assisted living, post-acute and long-term care, and outpatient medical real estate across the United States, the United Kingdom, and Canada. It makes money in two main ways: through its Senior Housing Operating Portfolio (SHOP), where it shares directly in the net operating income that property operators generate from residents, and through rents on triple-net leased seniors housing and care facilities plus outpatient medical buildings. Because SHOP income flows through to Welltower rather than being fixed rent, rising occupancy and room rates translate quickly into higher earnings, which is why the operating portfolio has become the company's main growth engine.

Full WELL guide

MPT vs WELL: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • MPT drivers: Tenant re-tenanting and rent recovery; Deleveraging and refinancing runway.
  • WELL drivers: Aging-demographics senior-housing tailwind; Operating-portfolio NOI growth.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: MPT carries roughly $9.7 billion of debt against a market cap near $1.85 billion, so financial leverage magnifies both gains and losses and refinancing risk is real given maturities in 2026 and 2027. For WELL, welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds.

MPT or WELL: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick MPT if you believe its drivers more; WELL if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MPT and WELL guides.

MPT vs WELL: the full fundamentals

MPT. MPT trades at about 0.41 times book value and 1.7 times sales, a steep discount to larger healthcare REITs like Welltower and Ventas, which reflects its leverage and tenant risk rather than a bargain hiding in plain sight. Q2 2026 brought about $259 million of revenue and a small net loss, after a Q1 profit that leaned on one-time tax and cash-rent items, and the $371 million Idaho hospital sale gives it cash to pay down debt at the cost of future rent. With a yield near 11.6 percent and Q3 results due October 29, the valuation is a classic high-yield, high-risk setup where the discount and the danger are two sides of the same coin.

WELL. Healthcare REITs are valued on funds from operations (FFO) rather than EPS, because standard net income is weighed down by large non-cash depreciation charges on real estate; that is why Welltower's GAAP P/E near 106x looks extreme. The key operating metric is senior-housing same-store NOI growth, now expected around 19% for 2026. At about $170 billion and a 1.45% yield, Welltower still carries a notably higher multiple than most healthcare REIT peers, and that premium is part of the investment case and part of the risk.

Headline figures (approximate, October 2026): MPT shows revenue (ttm) ~$1.1 billion (+1.9% YoY latest qtr), net income (ttm) ~-$32 million, market cap ~$1.85 billion, stock price ~$3.09 (YTD -39%); WELL shows revenue (ttm) ~$12.8 billion; Q2 2026 ~$3.54 billion, up ~39% YoY, net income (ttm) ~$1.55 billion GAAP (EPS ~$2.23), normalized ffo per share (2025) $5.29 (+~22.5%), 2026 senior-housing same-store noi growth ~19% expected after a raised outlook (original range 15% to 21%).

The bottom line: MPT vs WELL

MPT and WELL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MPT and WELL exposure against your real portfolio. It is not an investment adviser.

Wondering how MPT or WELL fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Investing in Medical Properties Trust with AI

Connect the broker you already use and ask Walnut's AI how MPT fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

What is the difference between MPT and WELL?

+

Medical Properties Trust, Inc. Welltower Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is MPT or WELL the better stock?

+

Neither is universally better. WELL is the larger incumbent; MPT is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, MPT or WELL?

+

On forward P/E (as of October 2026), MPT trades at 60.20x and WELL at 73.85x, so MPT is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both MPT and WELL?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of MPT vs WELL?

+

MPT: MPT carries roughly $9.7 billion of debt against a market cap near $1.85 billion, so financial leverage magnifies both gains and losses and refinancing risk is real given maturities in 2026 and 2027. Tenant concentration is a recurring problem: the 2024 Steward bankruptcy forced a dividend cut and asset sales, and in March 2026 MPT declared defaults on properties leased to Healthcare Systems of America, its third-largest tenant at about 8 percent of assets, sending the stock down about 8 percent in a day. That March 2026 disclosure triggered securities-fraud investigations by several plaintiff law firms, and MPT has faced securities litigation before tied to its 2019 to 2023 disclosures, so legal and disclosure risk is an ongoing overhang. The dividend is a live question: trailing net income is about -$32 million, the reported payout ratio is far above 100 percent, and a yield above 11 percent shows the market pricing in a possible cut. Asset sales reduce debt but also shrink rent, and BofA Securities trimmed its price target to $4.25 from $5 in August 2026. Hospital operators face reimbursement pressure, staffing shortages, and impairments. Walnut is not an investment adviser, and these factors make MPT materially more speculative than a typical healthcare REIT. WELL: Welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds. The senior-housing operating model also carries labor cost and staffing pressures and depends on occupancy holding up, so a weaker demand environment or wage inflation could compress margins. The stock trades at a premium valuation relative to many healthcare REIT peers, which leaves limited room for disappointment and makes it vulnerable to multiple compression. The company is also deploying capital aggressively, so acquisition execution, integration, and the cost of financing that growth are real risks if returns on new investments fall short. The valuation premium is stark on reported earnings: at $235.74 the stock trades near 106x trailing GAAP EPS and about 13x sales, and total debt stands near $19.7 billion. Several brokers trimmed targets in October 2026 (Barclays to $246 from $259, Jefferies to $260 from $275), and rising bond yields were cited in the trade press as slowing REIT deal activity.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell MPT or WELL; figures are approximate and dated (as of October 2026). Verify current data before investing.